Cartalax 20 mg

Strength 20 mg / 3 mLPurity HPLCForm Pre-filled penCOA Per batch

A short peptide bioregulator (Ala-Glu-Asp) studied for supporting cartilage and connective-tissue cell function, with research interest in joint and musculoskeletal endpoints.

Researched directions

Cartilage and chondrocyte research
Connective-tissue repair endpoints
Joint and musculoskeletal models
Gene-expression regulation studies

Request access to order Ask the lab

Available to verified researchers. Pricing and the batch Certificate of Analysis are shared on request.

About Cartalax

Cartalax is a peptide bioregulator studied for normalising the function of cartilage cells and supporting connective-tissue maintenance in joint and musculoskeletal research models.

Features

Cartalax is supplied in the NADOVA LABS GoQuick pre-filled pen — a graduated, ready-to-use subcutaneous delivery format that removes reconstitution and simplifies repeat-dose study designs. Each pen is prepared from HPLC-verified material, dose-marked on the barrel, and shipped refrigerated with a Certificate of Analysis available per batch.

Handling & compliance

This pre-filled pen is intended strictly for in-vitro and laboratory research. It is not a drug, supplement, or medical device, and is not for human or veterinary use. Store refrigerated at 2–8 °C, protect from light, and follow accepted laboratory practice; exact specifications for your lot are listed on its Certificate of Analysis.

Back to catalogue

Pen

Repair · Recovery

TB-500 15 mg

A thymosin β4 fragment studied for recovery, angiogenesis and tissue-repair models.

View 15 mg

Pen

Repair · Recovery blend

Tri-Heal 20 mg

A TB-500 + BPC-157 recovery blend studied for tissue repair and angiogenesis research.

View 20 mg

Pen

Cardiovascular · Bioregulator

Vasugen 10 mg

A vascular peptide bioregulator studied for endothelial and cardiovascular research.

View 10 mg